ð åèç
å¿
è â CDC Categories
- Category A (highest): anthrax, smallpox, plague, botulism, tularemia, VHF
- Category B: brucellosis, glanders, melioidosis, Q fever, ricin, etc.
- Category C: emerging â nipah, hantavirus, MDR-TB
å¿
è â Anthrax
- Bacillus anthracis; spores; multiple toxins
- Cutaneous (95% natural): painless black eschar
- Inhalational (bioterror main): biphasic + widened mediastinum on CXR/CT + mediastinitis + meningitis (45%+ mortality with Tx)
- Treatment: ciprofloxacin or doxycycline + 1-2 more à 60 days; antitoxin (raxibacumab, obiltoxaximab)
- Vaccine: BioThrax (military + post-exposure)
- 2001 letter attacks highlighted
å¿
è â Smallpox
- Eradicated 1980 (last natural case Somalia 1977)
- Stockpiles CDC + Russia
- Synchronous lesion progression + centrifugal
- Vaccines: ACAM2000 (live) + JYNNEOS (MVA-BN safer immunocompromise)
- Tecovirimat (TPOXX) for treatment
å¿
è â Plague
- Yersinia pestis; bipolar âsafety pinâ
- 3 forms: bubonic (LAP), septicemic (sepsis), pneumonic (bioterror; person-to-person)
- Pneumonic mortality 95%+ untreated
- Treatment: streptomycin or gentamicin IM/IV; doxy / cipro alternative; 10 days
- PEP: doxy or cipro à 7-10 d for contacts
- Isolation pneumonic plague
å¿
è â Botulism
- Clostridium botulinum toxin
- Most potent biological toxin known
- Descending flaccid paralysis + 4 Dâs
- BAT (Botulinum Antitoxin) ASAP + supportive ventilation
- BabyBIG infants
å¿
è â Tularemia
- Francisella tularensis; highly infectious
- Pneumonic form for bioterror
- Streptomycin or gentamicin IM/IV Ã 10 d
- PEP: doxy or cipro à 14 d
å¿
è â VHF Bioterror
- Ebola + Marburg + Lassa + JunÃn
- Severe + multi-organ + hemorrhage
- Supportive primarily
- Ribavirin (Lassa); mAbs (Ebola)
- Vaccines (Ervebo for Ebola)
å¿
è â Bioterror Recognition
- Unusual disease in unusual location
- Cluster of similar cases short timeframe
- Common exposure
- Multiple casualties without natural cause
- Unusual route (inhalational, pneumonic)
å¿
è â Response
- Recognition â notification (public health + CDC) â isolation â PPE â BSL-3+ specimens â empirical Tx â vaccination/PEP â decontamination â mass casualty + forensic